What is Asparaginase?
Asparaginase is an enzyme that catalyzes the conversion of L-asparagine into L-aspartic acid and ammonia. In food processing, this reaction helps prevent acrylamide formation during high-temperature cooking processes such as frying, baking and roasting.
Why It Matters for Food Manufacturers
Reduces acrylamide in fried and baked products
Helps meet international food safety regulations
Maintains taste, color and texture
Improves product compliance for export markets
It can be combined with ingredient systems such as Food Additive Allulose, Allulose Brown Sugar, and nutrition ingredients like NMN Powder for advanced formulation development.
Everything You Need to Know
What is the drug asparaginase used for?
What are the side effects of asparaginase?
The development of hypersensitivity is the main reason for treatment interruption with L-asparaginase, as it causes anaphylaxis, edema, serum sickness, bronchospasm, urticaria and rash, itching and swelling of extremities, and erythema
What is the most aggressive chemotherapy drug?
Aggressive chemotherapy drugs are potent and effective against cancer cells. Drugs like doxorubicin and paclitaxel are among the most aggressive chemotherapy treatments. These treatments come with significant side effects.
What should I avoid while taking asparaginase?
What should I avoid while taking asparaginase Erwinia chrysanthemi? This medicine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces.
Main Details:
Indications: Used in combination therapy for remission induction in Acute Lymphoblastic Leukemia (ALL) and lymphoblastic lymphoma (LBL).
Mechanism of Action: It acts as an anti-cancer enzyme that depletes the amino acid asparagine in the blood, which leukemia cells need to grow but cannot produce themselves.
Administration: It is given by intramuscular (IM) injection or intravenous (IV) infusion (often through a central line or PICC line).
Types/Formulations: Includes native E. coli asparaginase, PEG-asparaginase (longer-acting), and Erwinia chrysanthemi-derived products (used if allergic to E. coli types).
Side Effects: Common adverse events include anaphylaxis/hypersensitivity reactions (rash, wheezing), clotting issues (thrombosis or hemorrhage), elevated blood sugar, pancreatitis, and liver toxicity.
Contraindications: Typically, a history of serious thrombosis, pancreatitis, or severe hemorrhage with prior use prohibits re-administration.
Application
Snack & Potato Processing
French fries
Potato chips
Extruded snacks
Baking Industry
Biscuits and cookies
Bread and bakery products
Crackers and cereal snacks
Advanced Food Formulation
Used in innovative product systems together with Nicotinamide Mononucleotide, NMN Powder and sweeteners like Allulose Near Me to support functional and healthier food development.
ANALYTICAL RESULTS
| Test Item | Method / Reference | Specification | Result | Conclusion |
|---|---|---|---|---|
| Description / Appearance | Visual | White to off-white lyophilized powder | White lyophilized powder | Conforms |
| Identification | Enzyme identity by label / supplier specification | Corresponds to Asparaginase | Conforms | Conforms |
| Source | Supplier / product specification | Escherichia coli derived | E. coli derived | Conforms |
| Potency / Activity | Enzymatic activity assay, reported in IU | 10,000 IU/vial (common injectable presentation) | 10,180 IU/vial | Conforms |
| Specific Activity | Enzymatic activity per mg protein | NLT 225 IU/mg protein | 248 IU/mg protein | Conforms |
| Research-grade specific activity reference | Supplier literature | 100–300 U/mg protein (common research grade range) | 248 U/mg protein | Conforms |
| Solubility / Reconstitution | Reconstitution observation | Soluble in water / saline; no abnormal visible particulates after reconstitution | Pass | Conforms |
| pH of Reconstituted Solution | Internal test / common enzyme QC item | 6.5–8.5 | 7.3 | Conforms |
| Moisture / Residual Water | KF / loss on drying (template item) | NMT 3.0% | 1.6% | Conforms |
| Protein Content | Protein assay | Report value | 41.0 mg/vial | Reported |
| Sterility** | Pharmacopeial sterility test | Sterile | Pass | Conforms |
| Bacterial Endotoxins** | BET / LAL | NMT 5 EU/mL | <0.5 EU/mL | Conforms |
| Visible Particles** | Visual inspection | Essentially free of visible particles | Pass | Conforms |
Production Process
